Inventor · disambiguated record
Alvaro F. Guillem
Also filed as: GUILLEM ALVARO F
28 granted patents·21 pending applications·169 citations·filing 2012–2024
96Inventor score
Top patents by PatentIndex Score
49 records- 0196US8877255B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2013·Granted Nov 4, 2014·22 cites·24 claims
- 0295US9861658B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2015·Granted Jan 9, 2018·13 cites·14 claims
- 0395US8808750B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2013·Granted Aug 19, 2014·25 cites·29 claims
- 0493US11435364B2Methods of treating patients at risk for renal injury and renal failureRENIBUS THERAPEUTICS INC·Filed 2019·Granted Sep 6, 2022·5 cites·13 claims
- 0593US9913860B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2015·Granted Mar 13, 2018·6 cites·40 claims
- 0693US8802152B2Microporous zirconium silicate for the treatment of hyperkalemiaKEYSER DONALD JEFFREY·Filed 2012·Granted Aug 12, 2014·25 cites·22 claims
- 0792US11883371B2Stress test and treatment of chronic kidney diseaseRENIBUS THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·2 cites·9 claims
- 0892US9943637B2Microporous zirconium silicate and its method of productionZS PHARMA INC·Filed 2013·Granted Apr 17, 2018·9 cites·13 claims
- 0992US9844567B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2014·Granted Dec 19, 2017·10 cites·22 claims
- 1092US9662352B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2014·Granted May 30, 2017·10 cites·23 claims
- 1191US9457050B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2014·Granted Oct 4, 2016·12 cites·6 claims
- 1290US9592253B1Extended use zirconium silicate compositions and methods of use thereofZS PHARMA INC·Filed 2015·Granted Mar 14, 2017·8 cites·30 claims
- 1388US9707255B2Microporous zirconium silicate for the treatment of hyperkalemia in hypercalcemic patients and improved calcium-containing compositions for the treatment of hyperkalemiaZS PHARMA INC·Filed 2013·Granted Jul 18, 2017·14 cites·36 claims
- 1487US10398730B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2015·Granted Sep 3, 2019·3 cites·19 claims
- 1586US12178789B2Stress test and treatment of chronic kidney diseaseRENIBUS THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·0 cites·7 claims
- 1685US2023181631A1Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2022·Application pending·0 cites
- 1785US2025161235A1Stress test and treatment of chronic kidney diseaseRENIBUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1883US11292813B2Iron compositions and methods of making and using the sameRENIBUS THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·1 cites·3 claims
- 1981US12115138B2Tetrahydrocurcumin compositions, methods of making, and methods of using the sameRENIBUS THERAPEUTICS INC·Filed 2020·Granted Oct 15, 2024·1 cites·17 claims
- 2081US10300087B2Extended use zirconium silicate compositions and methods of use thereofZS PHARMA INC·Filed 2017·Granted May 28, 2019·2 cites·22 claims
- 2180US11834471B2Iron compositions and methods of making and using the sameRENIBUS THERAPEUTICS INC·Filed 2022·Granted Dec 5, 2023·0 cites·4 claims
- 2279US2024002427A1Novel iron compositions and methods of making and using the sameRENIBUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2378US11840552B2Iron compositions and methods of making and using the sameRENIBUS THERAPEUTICS INC·Filed 2022·Granted Dec 12, 2023·0 cites·7 claims
- 2477US12042501B2Metal protoporphyrin for treatment of BK virusRENIBUS THERAPEUTICS INC·Filed 2022·Granted Jul 23, 2024·0 cites·5 claims
- 2577US10413569B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2015·Granted Sep 17, 2019·1 cites·14 claims
- 2677US2024342191A1Metal protoporphyrin for treatment of bk virusRENIBUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2776US11406662B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2020·Granted Aug 9, 2022·0 cites·7 claims
- 2874US11965896B2Methods of treating patients at risk for renal injury and renal failureRENIBUS THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·4 claims
- 2974US11738044B2Extended use zirconium silicate compositions and methods of use thereofZS PHARMA INC·Filed 2019·Granted Aug 29, 2023·0 cites·13 claims
- 3068US10695366B2Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart diseaseZS PHARMA INC·Filed 2018·Granted Jun 30, 2020·0 cites·3 claims
- 3168US2018125884A1Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2017·Application pending·0 cites
- 3268US2014342017A1Microporous Zirconium Silicate for the Treatment of HyperkalemiaZS PHARMA INC·Filed 2014·Application pending·0 cites
- 3368US2025017876A1Novel tetrahydrocurcumin compositions, methods of making, and methods of using the sameRENIBUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3465US10335432B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2016·Granted Jul 2, 2019·0 cites·5 claims
- 3562US2018207350A1Microporous zirconium silicate and its method of productionZS PHARMA INC·Filed 2018·Application pending·0 cites
- 3661US2015196592A1Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2015·Application pending·0 cites
- 3757US2016051584A1Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart diseaseZS PHARMA INC·Filed 2014·Application pending·0 cites
- 3857US2014302175A1Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart diseaseZS PHARMA INC·Filed 2014·Application pending·0 cites
- 3956US2022079984A1Method for treating cancer with kidney protectionRENIBUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4054US2020171051A1Methods for treating renal injury by therapeutically upregulating p21RENIBUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4153US2016271174A1Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2014·Application pending·0 cites
- 4253US2016375054A1Microporous Zirconium Silicate for the Treatment of HyperkalemiaZS PHARMA INC·Filed 2014·Application pending·0 cites
- 4353US2015290242A1Microporous Zirconium Silicate for the Treatment of HyperkalemiaZS PHARMA INC·Filed 2014·Application pending·0 cites
- 4452US2021338708A1Method for treatment of coronavirus infectionRENIBUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4551US10695365B2Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2018·Granted Jun 30, 2020·0 cites·11 claims
- 4646US2015313938A1Microporous zirconium silicate for the treatment of hyperkalemia without co-administration of lithiumZS PHARMA INC·Filed 2014·Application pending·0 cites
- 4742US2015374748A1Microporous Zirconium Silicate for the Treatment of HyperkalemiaZS PHARMA INC·Filed 2015·Application pending·0 cites
- 4841US2015359821A1Microporous Zirconium Silicate for the Treatment of HyperkalemiaZS PHARMA INC·Filed 2015·Application pending·0 cites
- 4938US2016038538A1Microporous zirconium silicate for the treatment of hyperkalemiaZS PHARMA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alvaro F. Guillem files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →